U.K. Health Agency Discovers New Mpox Strain Amid Global Concerns

The U.K. Health Security Agency (UKHSA) has identified a new strain of the mpox virus in England, detected in an individual who recently returned from Asia. This discovery raises concerns about the evolving nature of the virus, which was previously known as Monkeypox. According to the agency, genetic testing revealed that the new strain contains elements from both clade 1 and clade 2 mpox subtypes.

Katy Sinka, a representative of the UKHSA, emphasized the importance of genomic testing, stating, “Our genomic testing has enabled us to detect this new mpox strain.” The agency is currently assessing the implications of this finding, which is significant given the potential for increased transmission and severity.

Understanding the New Mpox Strain

The UKHSA noted that the genome of the newly identified strain includes components of clade Ib and IIb mpox. Mpox is a viral infection related to smallpox, characterized by symptoms such as fever, body aches, and distinct skin lesions. The virus can be transmitted from infected animals to humans and can also spread between people through close physical contact.

According to Trudie Lang, a researcher at the University of Oxford and director of the Global Health Network, this case serves as a reminder of the global circulation and evolution of mpox. Lang stated, “It is of concern that there is an mpox case in the U.K., and of further concern that it is a new recombinant mpox virus.”

The World Health Organization (WHO) declared mpox a public health emergency in August 2024, following a significant outbreak primarily in the Democratic Republic of Congo. Although the WHO lifted this emergency status in September 2024 due to a decline in cases, the recent identification of a new strain underscores that the virus continues to pose a risk.

The Evolving Nature of Mpox

Historically, mpox transmission was largely animal-to-human, but recent outbreaks have shown a shift. The 2022 outbreak in Europe was primarily linked to close sexual contact, especially impacting gay and bisexual men. The latest strain, clade 1b, has demonstrated increased transmissibility through various forms of close contact.

Boghuma Titanji, an assistant professor of medicine at Emory University, noted, “The identification of a recombinant mpox strain containing elements of both clade I and clade II is precisely what experts in the field feared would happen.” This evolution highlights the need for ongoing vigilance and research into the virus’s behavior.

As of October 2024, nearly 48,000 confirmed mpox cases have been reported globally, resulting in 201 deaths across 94 countries. In the U.K., a vaccination program is in place for high-risk groups, including those with multiple sexual partners and individuals who participate in group sex.

Since 2022, the U.K. has experienced a low level of mpox cases, particularly with the spread of clade 2. The recent identification of this new strain reiterates the importance of public health measures and the need for continued monitoring of infectious diseases.